지난 주요뉴스 한국경제TV에서 선정한 지난 주요뉴스 뉴스썸 한국경제TV 웹사이트에서 접속자들이 많이 본 뉴스 한국경제TV 기사만 onoff
[PRNewswire] 카마고 CEO, 일본, 한국, 타이완 및 인도의 주요 기업과 회합 가져 2017-12-06 10:34:38
Officer, Ken Phelps, will be traveling to Tokyo, Seoul, Taipei, and Mumbai throughout December 2017. In each city, Phelps will hold seminars on 505(b)(2) drug development and meet with leading companies. Phelps' trip to the region follows a prior trip to China, during which Camargo held a...
[PRNewswire] 에어본와이어리스네트워크, 미나릭의 비행 레이저 터미널 공급받아 2017-12-06 09:53:45
to the Design and Manufacturing Services Agreement effective August 11, 2017. The confirmed shipment will allow ABWN to execute its next phase of testing, to conduct a two-plane test utilizing two Cessnas or equivalent planes (the Cessna Tests). The Cessna Tests build upon ABWN's successful May...
[PRNewswire] 4NEW, 비트코인에 필적하는 서비스 자금 확보 2017-12-05 18:41:03
4NEW’s [http://www.4new.co.uk/ ] Initial Coin Offering (FRNC) for its utility token is currently underway for the general public ending December 15, 2017. While this coin does not provide investors any share of the corporate profits currently, given that it is strictly speaking a utility token whic...
[PRNewswire] xChainge, 블록체인 기반의 P2P 거래로 암호거래소 대체 목표 세워 2017-12-05 18:24:21
service of collective investments to commercial real estate property. The crowdsale is scheduled to run between December 5th and December 30th, 2017. The team chose the Dutch auction model, similar to Raiden Network. At the start of the crowdsale each token will cost 0.05 ETH and the price will...
[PRNewswire] Switching to Tresiba(R) Benefits People with Diabetes 2017-12-05 18:06:56
American Diabetes Association (ADA), San Diego, California, US. June 2017. 4. EMA. Tresiba(R) Summary of Product Characteristics. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002498/WC500138940.pdf. Last accessed: December 2017. 5. Haahr H,...
[PRNewswire] Xultophy(R) Reported a Better Option than Basal-Bolus Insulin 2017-12-05 15:12:05
Last accessed: November 2017. 4. EMA. Xultophy(R) Summary of Product Characteristics. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002647/WC500177657.pdf. Last accessed: November 2017. Source: Novo Nordisk (끝) <저작권자(c) 연합뉴스, 무단...
[PRNewswire] Montage Technology Unveiled Jintide™ CPU Ecosystem at the 4th 2017-12-05 09:16:45
significant achievement of the three-party collaboration after the successful power-on of the Jintide™ SDV (Software Development Vehicle) in April 2017. By working closely with BIOS vendors, system software vendors and DIMM vendors, Montage has developed the complete Jintide™ CPU based solution a...
[PRNewswire] Xultophy(R) Offers Greater Blood Sugar and Body Weight 2017-12-04 16:18:40
can be accessed online at: http://dx.doi.org/10.1080/13696998.2017.1409228. About Xultophy(R) Xultophy(R) is a once-daily single injection fixed-ratio combination of long-acting insulin degludec and the glucagon-like peptide-1 (GLP-1) receptor agonist liraglutide in one pen. It is indicated for the...
[PRNewswire] 그룹M, 여섯 국가가 전 세계 광고 투자비 증가분의 68% 차지 발표 2017-12-04 14:55:03
investment in 2017 (ex-China). GroupM also believes the two will account for 186% of digital growth in 2017. This is exceedingly bad news for the balance of the digital publisher ecosystem. Amazon is on a fast-track to figure more prominently in the consolidation of digital ad investment with a few...
[PRNewswire] Infosys Appoints Salil S. Parekh as CEO and Managing Director 2017-12-03 11:50:01
Form 20-F for the fiscal year ended March 31, 2017. These filings are available at http://www.sec.gov. Infosys may, from time to time, make additional written and oral forward-looking statements, including statements contained in the company's filings with the Securities and Exchange Commission...